How Do Cannabis Companies Get Started When They Have No Money? Ask Judy Rinkus At The Cannabis Capital Conference In September
The Benzinga Cannabis Capital Conference (CCC) is coming to the great city of Chicago on September 13-14, 2022.
Sundial Growers Sets The Date For Special Meeting Of Shareholders, Voting On Consolidation Resolution
Sundial Growers Inc.’s (NASDAQ: SNDL) forthcoming annual and special meeting of shareholders will be held on July 21, 2022 at 1 p.m. MDT (3 p.m. EDT).
Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
U.S. stocks traded lower this morning following the release of jobs report for the month of June.
SciSparc Closer To Phase II-B Trial Of Its Dronabinol Based Drug For The Treatment Of Tourette Syndrome
SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, has started the process of preparing for an Investigational New Drug Application (“IND”) with the U.S.
Ascend Wellness Shares Purchased By Every Independent Director On The Board Of Directors
Ascend Wellness Holdings, Inc. (OTCQX: AAWH) (CSE:AAWH.U), a multi-state, vertically integrated cannabis operator, revealed that directors, Emily Paxhia, Scott Swid and Joseph Hinrichs, each made individual purchases of class A common shares in the open market totaling 60,352 shares<
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades.
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
Twitter And 20 Stocks Moving Premarket
Gainers
Seritage Growth Properties (NYSE: SRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the U.S. Securities and Exchange Commission.
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
RVL Pharmaceuticals plc (NASDAQ:RVLP) announced preliminary Q2 FY22 sales from Upneeq of $8.4 million, up 42% sequentially. Upneeq (oxymetazoline hydrochloride…